Calluna Pharma launches and announces EUR 75 million Series A financing to develop novel therapies for inflammatory and fibrotic diseases

Oxitope Pharma (Oxitope) and Arxx Therapeutics (Arxx), companies with a shared goal of leveraging the innate immune system to discover and develop disease modulating therapies, today announced their merger to form Calluna Pharma Inc. (Calluna).

UK’s asylum process takes a toll on the health and wellbeing of people seeking sanctuary

The UK’s asylum process is damaging to the health and wellbeing of people seeking sanctuary – according to a new study from the University of East

May 21, 2024

Biotest increases sales in the first half of 2024 by 35% to Euro 372 million – Biotech Investments

EQS-News: Biotest AG / Key word(s): Half Year Results/Half Year Results Biotest increases sales in the first half of 2024 by 35% to Euro 372

July 31, 2024

Healthcare leaders advocate for restoring Canada’s hypertension control program

A passionate plea for the re-establishment of Canada’s health coalition focused on hypertension prevention and control appears as an editorial in the Canadian Journal of

February 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.